Society of Hematologic Oncology

Tweets from Society of Hematologic Oncology

Latest from Society of Hematologic Oncology

Targeted Oncology Welcomes the Society of Hematologic Oncology to Its Strategic Alliance Partnership Program

January 08, 2020

Targeted Oncology, a multimedia resource that offers content and expert opinions on standard and emerging treatments in the oncology field, announces the addition of the Society of Hematologic Oncology to its Strategic Alliance Partnership program.

New Approaches to Increase Failure-Free Survival in Follicular Lymphoma

September 25, 2015

Failure-free survival (FFS) for patients with follicular lymphoma has had a lack of improvement, fueling interest in new treatment strategies that may offer promise for better outcomes.

Ibrutinib Shows Efficacy for the Treatment of Untreated and Relapsed/Refractory CLL

September 24, 2015

Single-agent ibrutinib (Imbruvica) data showed durable responses in patients with untreated or relapsed/refractory chronic lymphocytic leukemia (CLL).

Novel Therapies Show Promise in Mantle Cell Lymphoma

September 24, 2015

New combination strategies are required for heterogeneity of mantle cell lymphoma (MCL), in order to improve outcomes.

Immune Checkpoint Inhibitors in Lymphoma Spark Enthusiasm and Questions

September 24, 2015

Clinical evaluation suggests a role for immune checkpoint inhibition in the treatment of patients with lymphomas, but early success has also raised many questions.